Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
暂无分享,去创建一个
M. Cazzola | B. Zhivotovsky | L. Nilsson | B. Fadeel | E. Hellström-Lindberg | R. Tehranchi | A. Grandien | E. Travaglino | R. Wibom | R. Invernizzi | J. Samuelsson | R. Hast | A. Forsblom
[1] Guangjun Nie,et al. Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. , 2004, Blood.
[2] Hao Wang,et al. Global regulation of erythroid gene expression by transcription factor GATA-1. , 2004, Blood.
[3] U. Testa,et al. Apoptotic mechanisms in the control of erythropoiesis , 2004, Leukemia.
[4] T. Kuijpers,et al. Bid Truncation, Bid/Bax Targeting to the Mitochondria, and Caspase Activation Associated with Neutrophil Apoptosis Are Inhibited by Granulocyte Colony-Stimulating Factor , 2004, The Journal of Immunology.
[5] E. Hellström-Lindberg,et al. Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors. , 2004, Haematologica.
[6] L. Schwartz,et al. In vitro expansion of human cord blood CD36+ erythroid progenitors: temporal changes in gene and protein expression. , 2003, Experimental hematology.
[7] K. Akashi,et al. GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. , 2003, Immunity.
[8] M. Cazzola,et al. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. , 2003, Blood.
[9] P. Arosio,et al. Role of iron and ferritin in TNFα‐induced apoptosis in HeLa cells , 2003 .
[10] B. Zhivotovsky,et al. Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. , 2003, Blood.
[11] P. Arosio,et al. Role of iron and ferritin in TNFalpha-induced apoptosis in HeLa cells. , 2003, FEBS letters.
[12] D. Tang,et al. Early Mitochondrial Activation and Cytochrome c Up-regulation during Apoptosis* 210 , 2002, The Journal of Biological Chemistry.
[13] L. Hagenfeldt,et al. Measurement of ATP production and respiratory chain enzyme activities in mitochondria isolated from small muscle biopsy samples. , 2002, Analytical biochemistry.
[14] M. Cazzola,et al. Mitochondrial ferritin: a new player in iron metabolism. , 2002, Blood cells, molecules & diseases.
[15] P. Arosio,et al. Ferritin, iron homeostasis, and oxidative damage. , 2002, Free radical biology & medicine.
[16] F. Torti,et al. Regulation of ferritin genes and protein. , 2002, Blood.
[17] S. Orkin,et al. Transcriptional regulation of erythropoiesis: an affair involving multiple partners , 2002, Oncogene.
[18] Sten Orrenius,et al. Cytochrome c release from mitochondria proceeds by a two-step process , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[19] T. Kuijpers,et al. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. , 2002, Blood.
[20] A B Cantor,et al. Hematopoietic development: a balancing act. , 2001, Current opinion in genetics & development.
[21] Y. Yamashita,et al. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. , 2001, Blood.
[22] B. Joseph,et al. Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts , 2001, Leukemia.
[23] S. Dimauro,et al. The genetics and pathology of oxidative phosphorylation , 2001, Nature Reviews Genetics.
[24] Bengt Fadeel,et al. Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases , 2001, British journal of haematology.
[25] T. Matthes,et al. Increased apoptosis in acquired sideroblastic anaemia , 2000, British journal of haematology.
[26] G. Kroemer,et al. The mitochondrion in cell death control: certainties and incognita. , 2000, Experimental cell research.
[27] Y. Saunthararajah,et al. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? , 2000, Seminars in hematology.
[28] P. Vogt,et al. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Srinivasula,et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 , 1999, Nature.
[30] C. Lacombe,et al. Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction , 1999, British journal of haematology.
[31] Parker,et al. ‘Low‐risk’ myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐ versus anti‐apoptotic bcl‐2‐related proteins , 1998, British journal of haematology.
[32] A. Barrett,et al. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte‐mediated inhibition of CFU‐GM and alterations in T‐cell receptor Vβ profiles , 1998, British journal of haematology.
[33] I. Dybedal,et al. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. , 1998, Blood.
[34] Sten Orrenius,et al. Injected cytochrome c induces apoptosis , 1998, Nature.
[35] Y Yoshida,et al. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. , 1998, Haematologica.
[36] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.
[37] L. Hoefsloot,et al. Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand. , 1996, Leukemia.
[38] J. Bennett,et al. Hypocellular myelodysplastic syndromes (MDS): new proposals , 1995, British journal of haematology.
[39] M. Carroll,et al. Erythropoietin receptor signals both proliferation and erythroid-specific differentiation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[40] S. Asano,et al. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes. , 1993, International journal of hematology.
[41] Y. Ikawa,et al. GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression. , 1991, Nucleic acids research.
[42] G. Stamatoyannopoulos,et al. Differentiation kinetics and globin gene expression by circulating human BFUe in suspension cultures. , 1990, Experimental hematology.
[43] H. Uchino,et al. Refractory myelodysplastic anaemias with hypocellular bone marrow. , 1988, Journal of clinical pathology.